A Aralex Aachen research explorer

November 18, 2020 article

Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial

The Lancet Diabetes & Endocrinology

DOI: 10.1016/s2213-8587(20)30344-2 OpenAlex

Authors 0

Author list not loaded yet.

Cited by 6 stored of 73

Therapy of Type 2 Diabetes
2024 Experimental and Clinical Endocrinology & Diabetes article Medicine Diabetes Treatment and Management Open access

6

citations
Therapie des Typ-2-Diabetes
2024 Die Diabetologie article Medicine Diabetes Treatment and Management

1

citations
Therapie des Typ-2-Diabetes
2023 Die Diabetologie article Medicine Diabetes Treatment and Management Open access

1

citations
Recurrent cardiovascular events in patients with type 2 diabetes and haemodialysis: analysis from the 4D Study
2023 Clinical Kidney Journal article Medicine Lipoproteins and Cardiovascular Health Open access

7

citations
Incident and recurrent hypoglycaemia with linagliptin and glimepiride over a median of 6 years in the CAROLINA cardiovascular outcome trial
2023 Diabetes Obesity and Metabolism article Medicine Diabetes Treatment and Management Open access

4

citations
Therapie des Typ-2-Diabetes
2022 Die Diabetologie article Medicine Diabetes Treatment and Management Open access

5

citations

6 results

References 0